Rankings
▼
Calendar
AXGN Q4 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$60M
+21.3% YoY
Gross Profit
$44M
74.1% margin
Operating Income
-$10M
-16.3% margin
Net Income
-$13M
-22.0% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
-0.3%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$2M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$222M
Total Liabilities
$93M
Stockholders' Equity
$129M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$60M
$49M
+21.3%
Gross Profit
$44M
$38M
+18.2%
Operating Income
-$10M
$2M
-584.5%
Net Income
-$13M
$450,000
-3023.6%
← FY 2025
All Quarters